Centene Corp. CNC
NYSE · Healthcare · Medical - Healthcare Plans
$63.78
Close on Fri, 20 Nov 2026 · market value $31.6B
What the price is betting on
Below its recordAt $64, the price assumes revenue shrinks about 34% a year for five years, from $204B to about $35.1B by FY2030. That is about the same as what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 9.3% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than CNC? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$147
Base
$158
Bull
$172
Today $64
- Bear $147. Cash flow grows -1% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $158. Cash flow grows 1% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $172. Cash flow grows 3% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$184B$200B, on the path
- FY2027$122B$196B, on the path
- FY2028$80.3B$200B, on the path
- FY2029$53.1B$211B, on the path
- FY2030$35.1B$213B, on the path
Each year's revenue at −34% growth from $204B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Healthcare Plans · listed on NYSE
- Revenue, FY2025
- $195B
- Growth, 3 years a year
- 11%
- Cash margin
- 2.2%
- Net cash
- $2.2B
- Shares, 3-year change
- −16%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.